Submitted by Anonymous (not verified) on 8 June 2026 - 13:08
Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation: 18/12/2020, Revision: 18, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation: 18/12/2020, Revision: 18, Status: Authorised